Abstract
Background Crohn’s Disease patients require life-long follow-up resulting frequent hospital visits. Usefulness of telehealth has been established in remote management of Crohn’s disease but mobile technology’s role is missing. We aimed to determine the feasibility and effectiveness of smartphone-based real-time video visits.
Methods We prospectively studied 139 patients either at a traditional (FTF) or online clinic (OLV) in a university hospital between March 2020-September 2020. We measured patients’ satisfactions, disease activity, visit outcomes, socioeconomic parameters, and travel expenses to assess the effectiveness and acceptance of OLV.
Results Satisfaction scores were significantly higher at OLV compared to FTF (89.58±9.93 vs 70.85±18.51, p<0.001). The Cronbach Alpha reliability coefficient of the VSQ9 scale was 0.878. Median 47km travel distance and 49 minutes travel time per visit saved with OLV. An average of US$12.24 potential travel costs were saved per appointment. Eighty-five per cent of the patients met the needs at online visits and did not require a face-to-face visit.
Conclusions Smartphone-based real-time video visit telehealth model for distant management of Crohn’ disease had high acceptance. The model was easy to implement, effective and saved travel cost and time.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04754620
Funding Statement
This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was performed according to the principles of the Declaration of Helsinki. The protocol was reviewed and approved by the Kocaeli University Ethical Committee of Clinical Research (Project number: GOKAEK-2020/7.12. 2020/123)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
email: alierkan.duman{at}kocaeli.edu.tr,
Conflicts of Interest and Source of Funding: Hasan Yılmaz has been a speaker at educational symposia sponsored by The Ferring Pharmaceuticals and consulted on the advisory board of The Arena Pharmaceuticals. Ali Erkan Duman has educational support and has been a speaker at educational symposia sponsored by The Ferring Pharmaceuticals. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Availability of data and material: Researchers can reach the dataset of this study publicly. (Yılmaz, Hasan (2021), “Smartphone-Based Videoconference Telehealth for patients with Crohn’s Disease”, Mendeley Data, V1, http://dx.doi.org/10.17632/c5d3v8fd5r.1)
Data Availability
Researchers can reach the dataset of this study publicly. (Yılmaz, Hasan (2021), "Smartphone-Based Videoconferance Telehealth for patients with Crohn's Disease", Mendeley Data, V1,
